 |
|
Rheumatoid Arthritis Studies into this chronic, autoimmune disease explore the relationship between the condition and hormonal optimization. With that, the effects of such therapy are being examined. Review current research and medical articles on rheumatoid arthritis to gain insights and potential methodologies that may effectively control systematic inflammation and related symptoms. Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM study.pdf
According to this study, based on TT
concentration, the prevalence of
hypogonadism in men reporting to
primary care offices was estimated
to be 38.7%. The medical conditions
that occurred significantly more
frequently among hypogonadal men
than eugonadal men included
increased BMI, hypertension,
hyperlipidaemia, diabetes, and
asthma or COPD. As men age, they are
susceptible to conditions that share
many of the same symptoms similar to
hypogonadism. The presence of these
conditions may, in effect, mask
underlying hypogonadism and
negatively impact quality of life.
The Serum Growth Hormone to
Somatostatin Ratio is Skewed Upward
in Rheumatoid Arthritis Patients.pdf
The
aim of this study was to investigate
the effects of HRT on the serum
levels of hormones and cytokines
regulating bone turnover in 88
postmenopausal women with active
rheumatoid arthritis (RA) randomly
allocated to receive HRT plus
calcium and vitamin D3 or calcium
and vitamin D3 alone for 2 years. Inappropriate Serum Levels of IGF-I and IGFBP-3 in Patients with Rheumatoid Arthritis.pdf
In
this study, it was found that
the ratio of IGF-I to
IGFBP-3 in RA patients was
significantly
lower than that in controls.
These findings suggest that that
an inappropriate
balance of IGF-I and IGFBP-3 levels
may reduce
the availability of IGF-I and be
involved in pathogenesis of
RA.
This
study concluded that increased
levels of IGFBPs in RA may result in
the reduced availability of free
IGFs that can bind to IGF receptors.
The observed changes in the IGF
system may thus participate in the
catabolic processes in rheumatoid
arthritis. Hypothalamo-Pituitary-Adrenal Axis and Growth Hormone Axis in Patients with Rheumatoid Arthritis.pdf
The
findings of this study indicate that
there is an impairment in HPA and GH
axis in patients with active and
remitted RA. The site of this
impairment is probably hypothalamus
and/or pituitary gland.
The
finding that IGF-1 is present in
levels about one-half as great in SF
as compared with serum suggests that
IGF-1 may be produced in lesser
amounts or is utilized by the
patient in customary joint function.
The finding that GH is present in SF
at values twice as high, or more, of
serum levels in inflammatory
arthritides suggests that GH may
play a role in the pathophysiology
of arthritic disorders.
Increase of Bone Mineral Density and
Anabolic Variables in Patients with
Rheumatoid Arthritis Resistant to
Methotrexate After Cyclosporin A
Therapy.pdf Anterior Pituitary Function in Patients with Newly Diagnosed Rheumatoid Arthritis.pdf
In
this study, a combined test for
total anterior pituitary reserve was
performed in 10 patients with newly
diagnosed untreated RA. Before and
after stimulation with the
respective hypothalamic releasing
hormones, RA patients showed no
difference in plasma concentrations
of adrenocorticotrophic hormone
(ACTH), cortisol, prolactin (PRL)
and thyroid-stimulating hormone (TSH)
when compared to healthy controls.
This
study concluded that the effects of
CysA on IGF-I may explain some of
the clinical, immunologic, and
metabolic results during CysA
treatment of rheumatic diseases.
|
